The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma

Abstract Background The collagen β (1-O) glycosyltransferase 25 domain 1 (GLT25D1), a crucial collagen-modifying enzyme (CME), plays a pivotal role in multiple pathophysiological processes. However, its prognostic and biological roles in hepatocellular carcinoma (HCC) have not been reported. Methods...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Sheng Qiu, Hongdong Han, Hongmin Zhang, Mengliu Yang, Hao Wang, Ke Li, Ling Li, Gangyi Yang
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2025-03-01
Serie:	Cancer Cell International
Ämnen:	Collagen modification enzyme-related genes GLT25D1 Hepatocellular carcinoma Immunosuppression Alignant phenotypes
Länkar:	https://doi.org/10.1186/s12935-025-03715-z
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!